JPH08164186A - Method for sterilizing liquid agent made into single agent containing reducing sugar and bicarbonate - Google Patents

Method for sterilizing liquid agent made into single agent containing reducing sugar and bicarbonate

Info

Publication number
JPH08164186A
JPH08164186A JP6310264A JP31026494A JPH08164186A JP H08164186 A JPH08164186 A JP H08164186A JP 6310264 A JP6310264 A JP 6310264A JP 31026494 A JP31026494 A JP 31026494A JP H08164186 A JPH08164186 A JP H08164186A
Authority
JP
Japan
Prior art keywords
reducing sugar
bicarbonate
liquid agent
soft plastic
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP6310264A
Other languages
Japanese (ja)
Inventor
Junichiro Watanabe
純一郎 渡辺
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Terumo Corp
Original Assignee
Terumo Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Terumo Corp filed Critical Terumo Corp
Priority to JP6310264A priority Critical patent/JPH08164186A/en
Publication of JPH08164186A publication Critical patent/JPH08164186A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

PURPOSE: To make it possible to suppress the decomposition of a reducing sugar and to suppress the fluctuation in pH by housing the liquid agent into a soft plastic bag, thereafter, packaging the bag with a packaging material having a high gas barrier property then, thermally sterilizing the bag in a method for sterilizing the liquid agent made into the single agent contg. the reducing sugar and bicarbonate. CONSTITUTION: The liquid agent made into the single agent contg. a reducing sugar and a bicarbonate is housed into the soft plastic bag, is then vacuum packaged with the packaging material having the high gas barrier property and is so treated as to be thermally sterilized at the time of sterilizing the pharmaceutical prepn. which is a liquid agent for medical treatment, such as perfusate, for artificial kidneys, contg. the reducing agent and bicarbonate ions, and made into the single agent. The materials of the soft plastic bag include, for example, a polyethylene, polypropylene, polyvinyl chloride, etc., and the materials which withstand the thermal sterilization are more preferable. Materials which withstand the thermal sterilization and gas carbon dioxide permeability of <=50ml/m<2> .24hr.atm (25 deg.C-70%RH) are more preferable as the packaging material and include, for example, a polyethylene terephthalate, etc.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は還元糖と重炭酸を含有す
るpHが弱酸性から中性の一剤化された液剤を還元糖の
分解を抑制しつつ安定に滅菌する方法に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a method for stably sterilizing a solution containing a reducing sugar and bicarbonate and having a weakly acidic to neutral pH, while suppressing decomposition of the reducing sugar.

【0002】[0002]

【従来の技術及びその問題点】従来より、輸液、人工腎
臓用潅流液、濾過型人工腎臓用補充液、腹膜透析液等に
重炭酸を配合した場合、pHが高くなることにより配合
された還元糖の分解による着色が問題となっている。そ
のため還元糖と重炭酸イオンを含む、輸液、人工腎臓用
潅流液、濾過型人工腎臓用補充液、腹膜透析液等の医療
用液剤は、2剤に分割され2つの容器に別々に収容され
用時に混合される。かかる製剤は、その使用時に煩雑な
無菌的混合操作を必要とするが、その混合時には細菌汚
染の恐れを回避し難い。
2. Description of the Related Art Conventionally, when bicarbonate is added to an infusion solution, an artificial kidney perfusion solution, a filtration type artificial kidney replenishment solution, a peritoneal dialysis solution, etc., the reduction caused by the increase in pH is caused. Coloring due to sugar decomposition is a problem. Therefore, medical fluids containing reducing sugars and bicarbonate ions, such as infusions, artificial kidney perfusates, filtration artificial kidney replenishers, and peritoneal dialysis fluids, are divided into two parts and stored separately in two containers. Sometimes mixed. Although such a preparation requires a complicated aseptic mixing operation at the time of use, it is difficult to avoid the risk of bacterial contamination during the mixing.

【0003】このような点を解決すべく一つの容器に別
々の室を設けて収容する方法が研究されているが(例え
ば、特開昭61−355,特公昭63−19149,特
開平5−31153,特開平5−5138)、使用時の
混合操作がなお煩雑であったり、2室を分けている隔壁
やチップの剥離や破壊からなる混合操作により微粒子が
生成したり、容器の部品点数の増加や構造が複雑になっ
て信頼性が低下する等の品質上の問題がある。
In order to solve such a point, a method of providing a single container with separate chambers has been studied (for example, JP-A-61-355, JP-B-63-19149, and JP-A-5-195149). 31153, JP-A-5-5138), the mixing operation at the time of use is still complicated, and fine particles are generated by the mixing operation that consists of peeling or destruction of partition walls and chips dividing the two chambers, and the number of parts of the container There is a problem in quality such as increase in number and complexity of structure, and decrease in reliability.

【0004】これらのことから、還元糖と重炭酸を一剤
化した製剤の開発が強く望まれているが、重炭酸の添加
によって液性が弱酸性から中性となる液剤に還元糖を配
合したものは、経時的に炭酸ガスの発生・揮散が生じる
ため製造工程や製品の長期保管時にpHの上昇が起こ
り、品質管理上の問題となる。さらにこのような液剤
は、pHの上昇により高圧蒸気滅菌または熱水滅菌等に
より加えられる熱で還元糖の分解が進行し、液剤の着色
が起こってしまい、これを回避するには炭酸ガス雰囲気
下での滅菌が必要になるなどの製造上の困難が生じる。
このような困難から、かかる液剤は未だに市販されてい
ない。
From these things, it is strongly desired to develop a preparation in which reducing sugar and bicarbonate are combined into one agent. However, by adding bicarbonate, the reducing sugar is mixed with a liquid agent whose liquidity changes from weakly acidic to neutral. Since the carbon dioxide gas is generated and volatilized over time, the pH of the above product increases during the manufacturing process and long-term storage of the product, which causes a problem in quality control. Furthermore, in such a liquid agent, reducing sugar is decomposed by heat applied by high-pressure steam sterilization or hot water sterilization due to an increase in pH, and coloring of the liquid agent occurs. To avoid this, under a carbon dioxide gas atmosphere. Manufacturing difficulties such as sterilization at room temperature occur.
Due to such difficulties, such liquid preparations have not yet been marketed.

【0005】[0005]

【発明が解決しようとする課題】従って、本発明の目的
は還元糖と重炭酸を一剤化した液剤の安定な滅菌方法を
提供することにある。
SUMMARY OF THE INVENTION Accordingly, an object of the present invention is to provide a stable sterilization method for a liquid preparation in which reducing sugar and bicarbonate are combined.

【0006】[0006]

【課題を解決するための手段】本発明者は、上記目的よ
り鋭意研究を重ねた結果、還元糖及び重炭酸を一剤化し
た液剤を、軟質プラスチックバッグに収容した後ガスバ
リアー性の高い包材で真空包装し、高圧蒸気滅菌または
熱水滅菌などの熱滅菌を行うことにより、還元糖の分解
を抑制するだけでなく、pHの変動をも抑制できること
を見い出し、本発明を完成するに至った。
Means for Solving the Problems As a result of intensive studies conducted by the inventor of the present invention, the present inventors have found that after packaging a liquid formulation containing reducing sugar and bicarbonate into a soft plastic bag, the liquid package has a high gas barrier property. It was found that not only the decomposition of reducing sugars can be suppressed but also the fluctuation of pH can be suppressed by vacuum packaging with a material and performing heat sterilization such as high-pressure steam sterilization or hot water sterilization, thus completing the present invention. It was

【0007】即ち本発明は、還元糖と重炭酸を含有する
一剤化された液剤の滅菌法において、前記液剤を軟質プ
ラスチックバッグに収容し、次に前記液剤を収容した前
記軟質プラスチックバッグをガスバリアー性の高い包材
で真空包装し、熱滅菌することを特徴とする液剤の滅菌
法である。
That is, according to the present invention, in a method for sterilizing a one-component liquid agent containing reducing sugar and bicarbonate, the liquid agent is contained in a soft plastic bag, and then the soft plastic bag containing the liquid agent is gasified. This is a liquid agent sterilization method characterized in that it is vacuum-packed in a packaging material having a high barrier property and heat-sterilized.

【0008】本発明により滅菌される還元糖と重炭酸を
含有する一剤化された液剤とは、特に限定されないが、
輸液、人工腎臓用潅流液、濾過型人工腎臓用補充液、腹
膜透析液等の医療用の液剤が挙げられる。
Although the reducing sugar and the monocarbonate-containing liquid preparation containing bicarbonate to be sterilized according to the present invention are not particularly limited,
Examples of medical fluids include infusion solutions, perfusion solutions for artificial kidneys, replenishers for filtration type artificial kidneys, and peritoneal dialysis solutions.

【0009】またその組成としては特に限定されない
が、還元糖の配合量は10W/V%以下、好ましくは5
W/V%以下であり、重炭酸イオンの配合量は1〜40
mEq/lの範囲で含有するものが好ましい。その他の
配合成分としては特に制限されるものはなく、ナトリウ
ム、カリウム、カルシウム、マグネシウム、クロール、
リン酸、有機酸、微量元素等が挙げられる。
The composition of the reducing sugar is not particularly limited, but the reducing sugar content is 10 W / V% or less, preferably 5%.
W / V% or less, and the amount of bicarbonate ion is 1 to 40
Those contained in the range of mEq / l are preferable. Other ingredients are not particularly limited, sodium, potassium, calcium, magnesium, chlor,
Examples thereof include phosphoric acid, organic acids, trace elements and the like.

【0010】カルシウム及びマグネシウムを配合した際
には、炭酸塩の沈澱が生じる問題があるが、輸液、人工
腎臓用潅流液、濾過型人工腎臓用補充液、腹膜透析液等
で通常用いられる量では、適当なpHに維持すれば40
mEq/l以下の重炭酸イオン濃度では問題なく、ま
た、沈澱を抑制するキレート剤(例えば、クエン酸,コ
ンドロイチン硫酸,グリシルグリシン等)を配合するこ
とによっても回避することができる。前記適当なpHと
は弱酸性から中性の範囲であり、具体的にはpH5〜8
の範囲である。
When calcium and magnesium are mixed, there is a problem that carbonate precipitation occurs, but in the amounts usually used for infusion, perfusion solution for artificial kidney, replenishing solution for filtration type artificial kidney, peritoneal dialysis solution, etc. , 40 if maintained at an appropriate pH
There is no problem at a bicarbonate ion concentration of mEq / l or less, and it can be avoided by adding a chelating agent that suppresses precipitation (for example, citric acid, chondroitin sulfate, glycylglycine, etc.). The suitable pH is in the range of weak acidity to neutrality, specifically pH 5-8.
Range.

【0011】また本発明で滅菌される液剤に配合される
還元糖としては、通常のものでよく、例えばグルコー
ス、マルトース等が挙げられる。
The reducing sugar to be added to the liquid preparation to be sterilized according to the present invention may be an ordinary reducing sugar such as glucose and maltose.

【0012】本発明に用いる軟質プラスチックバッグの
材質としては、輸液用プラスチック容器試験に適合する
ものであれば通常のものでよく、例えばポリエチレン、
ポリプロピレン、ポリ塩化ビニル、エチレン−酢酸ビニ
ル共重合体等が挙げられ、特に熱滅菌に耐えられるもの
であることが望ましい。具体的には、テルパック、血液
バッグ、メディファイアルI−300(各テルモ製)な
どが挙げられる。
The material of the soft plastic bag used in the present invention may be any ordinary one as long as it is compatible with the infusion plastic container test, such as polyethylene,
Examples thereof include polypropylene, polyvinyl chloride, ethylene-vinyl acetate copolymer and the like, and those which can withstand heat sterilization are particularly desirable. Specific examples include Terpack, blood bag, Medifial I-300 (manufactured by Terumo) and the like.

【0013】本発明に用いるガスバリアー性の高い包材
としては、熱滅菌に耐えられるもので、炭酸ガス透過性
が50ml/m2・24hr・atm(25℃−70%RH)以下の
ものが望ましく、例えばポリエチレンテレフタレート
(PET)、エチレンビニルアルコール共重合体(EV
OH)、ポリ塩化ビニリデン(PVDC)、ポリアミド
(PA)、アルミラミネート等の材質のものやこれらの
材質の組み合わせからなる多層フィルムからなるもの、
あるいはこれらの多層フィルムに酸化金属やセラミック
を蒸着コートしたもの等が挙げられる。具体的には、P
ET/EVOH/NY(ナイロン)/CPP(ポリプロ
ピレン)(富士産業社製)、PET/アルミナ蒸着PE
T/CPP(富士産業社製)、酸化金属蒸着PET/P
VDC−MA(メチルアクリレート)/PA/CPP
(細川洋行社製)、PET/SiOX蒸着PET/CP
P(凸版印刷社製)などが挙げられる。
The packaging material having a high gas barrier property used in the present invention is one that can withstand heat sterilization and has a carbon dioxide gas permeability of 50 ml / m 2 · 24 hr · atm (25 ° C-70% RH) or less. Desirably, for example, polyethylene terephthalate (PET), ethylene vinyl alcohol copolymer (EV
OH), polyvinylidene chloride (PVDC), polyamide (PA), aluminum laminate, etc., or a multilayer film made of a combination of these materials,
Alternatively, those obtained by depositing metal oxide or ceramic on these multilayer films by vapor deposition may be used. Specifically, P
ET / EVOH / NY (nylon) / CPP (polypropylene) (manufactured by Fuji Sangyo Co., Ltd.), PET / alumina deposited PE
T / CPP (Fuji Sangyo Co., Ltd.), metal oxide vapor deposition PET / P
VDC-MA (methyl acrylate) / PA / CPP
(Manufactured by Hosokawa Yoko), PET / SiO X vapor deposition PET / CP
P (manufactured by Toppan Printing Co., Ltd.) and the like.

【0014】容器をガスバリアー性包材で包装する形態
については、通常の工程によって行われている真空包装
でよい。
As for the form of packaging the container with the gas barrier packaging material, vacuum packaging which is carried out by an ordinary process may be used.

【0015】本発明において熱滅菌としては、例えば高
圧蒸気滅菌や熱水滅菌などが挙げられる。高圧蒸気滅菌
を行う場合、温度は100〜133℃、より好ましくは
100〜126℃、時間は1〜120分間、より好まし
くは5〜60分間の条件下で行うことが好ましい。熱水
滅菌滅菌を行う場合、温度は60〜100℃、より好ま
しくは80〜100℃、時間は30〜60分間、より好
ましくは30〜40分間の条件下で行うことが好まし
い。
Examples of the heat sterilization in the present invention include high-pressure steam sterilization and hot water sterilization. When high-pressure steam sterilization is performed, it is preferable that the temperature is 100 to 133 ° C., more preferably 100 to 126 ° C., and the time is 1 to 120 minutes, more preferably 5 to 60 minutes. When hot water sterilization is performed, it is preferable that the temperature is 60 to 100 ° C., more preferably 80 to 100 ° C., and the time is 30 to 60 minutes, more preferably 30 to 40 minutes.

【0016】[0016]

【実施例】以下、実施例及び比較例を示し、本発明をさ
らに詳しく説明する。 (実施例1〜8)表12に示す濃度になるようにグルコ
ース、マルトース、塩化ナトリウム、塩化カリウム、塩
化カルシウム(2水塩)、塩化マグネシウム(6水
塩)、乳酸ナトリウム、炭酸水素ナトリウムをそれぞれ
注射用水に溶解した。
The present invention will be described below in more detail with reference to Examples and Comparative Examples. (Examples 1 to 8) Glucose, maltose, sodium chloride, potassium chloride, calcium chloride (dihydrate), magnesium chloride (hexahydrate), sodium lactate, and sodium hydrogencarbonate were each adjusted to have the concentrations shown in Table 12. Dissolved in water for injection.

【0017】これに炭酸ガスまたは窒素−炭酸混合ガス
を通して薬液のpHを表中の値に調整し、0.45μmメ
ンブランフィルターでろ過して、200mlずつ軟質プラ
スチック容器(メディファイアルI−300,テルモ
製)に充填した。これを各ガスバリアー性の高い包材
(EVOH[PET/EVOH/NY/CPP](富士
産業社製)、PET−Al[PET/アルミナ蒸着PE
T/CPP](富士産業社製)、PVDC[酸化金属蒸
着PET/PVDC−MA/PA/CPP](細川洋行
社製),PET−Si[PET/SiOX蒸着PET/
CPP](凸版印刷社製))で真空包装した後に、高圧
蒸気滅菌(108℃,25分間)した。
The pH of the drug solution was adjusted to the value shown in the table by passing carbon dioxide gas or a nitrogen-carbonate mixed gas through this, and the solution was filtered through a 0.45 μm membrane filter to obtain 200 ml each in a soft plastic container (Medical I-300, Terumo). Manufactured). This is a packaging material with high gas barrier properties (EVOH [PET / EVOH / NY / CPP] (manufactured by Fuji Sangyo Co., Ltd.), PET-Al [PET / alumina vapor deposition PE]
T / CPP] (manufactured by Fuji Sangyo Co., Ltd.), PVDC [metal oxide deposition PET / PVDC-MA / PA / CPP] (manufactured by Hosokawa Yoko), PET-Si [PET / SiO X deposition PET /
After vacuum packaging with CPP] (manufactured by Toppan Printing Co., Ltd.), high pressure steam sterilization (108 ° C., 25 minutes) was performed.

【0018】上述の製造で得た液剤は滅菌後24時間以
上経た後に、着色及び沈澱を観察し、pHを測定した。
また、グルコース及びマルトースの分解の指標となる2
84nmにおける吸光度を測定した。結果を表1に示
す。
The liquid agent obtained by the above-mentioned production was sterilized for 24 hours or more, and then, coloring and precipitation were observed and pH was measured.
It also serves as an index for the decomposition of glucose and maltose.
The absorbance at 84 nm was measured. The results are shown in Table 1.

【0019】(比較例1,2)実施例と同様に操作して
軟質プラスチック容器に充填した液剤を、無包装のもの
を比較例1、ガスバリアー性の低い包材(炭酸ガス透過
性:100ml/m2・24hr・atm 以上,NY[CPP/N
Y/CPP](富士産業社製))で真空包装したものを
比較例2とし、実施例と同様に高圧蒸気滅菌し、同様に
評価を行った。結果を表1に示す。
(Comparative Examples 1 and 2) A liquid agent filled in a soft plastic container in the same manner as in Examples was used as an unpackaged Comparative Example 1, a packaging material having a low gas barrier property (carbon dioxide gas permeability: 100 ml). / m 2 · 24 hr · atm or more, NY [CPP / N
Y / CPP] (manufactured by Fuji Sangyo Co., Ltd.) was vacuum-packed as Comparative Example 2, and high-pressure steam sterilization was performed in the same manner as in Example, and the same evaluation was performed. The results are shown in Table 1.

【0020】[0020]

【表1】 [Table 1]

【0021】結果に示すように、各実施例では着色、p
H、還元糖の分解は見られなかったが、各比較例におい
てはいずれも着色、pH、還元糖の分解が確認された。
また、各実施例及び各比較例において沈殿は見られなか
った。
As shown in the results, in each example, coloring, p
No decomposition of H or reducing sugar was observed, but in each comparative example, coloration, pH, and decomposition of reducing sugar were confirmed.
Further, no precipitation was observed in each of the examples and the comparative examples.

【0022】[0022]

【発明の効果】上述した通り、本発明の滅菌法により、
還元糖と重炭酸を含有する一剤化された液剤は、還元糖
の分解・着色やpHの上昇等を防止しながら高圧蒸気滅
菌または熱水滅菌を行うことができる。従って本発明
は、主に、輸液、人工腎臓用潅流液、濾過型人工腎臓用
補充液、腹膜透析液等の還元糖と重炭酸が一剤化されて
いる医療用液剤の滅菌法として有効に使用できる。
As described above, according to the sterilization method of the present invention,
The one-component liquid agent containing reducing sugar and bicarbonate can be subjected to high-pressure steam sterilization or hot water sterilization while preventing decomposition and coloring of reducing sugar and increase in pH. Therefore, the present invention is mainly effective as a sterilization method for medical fluids in which reducing sugar and bicarbonate are combined into a single solution, such as infusion solution, artificial kidney perfusion solution, filtration type artificial kidney replenisher solution, and peritoneal dialysis solution. Can be used.

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】還元糖と重炭酸を含有する一剤化された液
剤の滅菌法において、前記液剤を軟質プラスチックバッ
グに収容し、次に前記液剤を収容した前記軟質プラスチ
ックバッグをガスバリアー性の高い包材で包装し、熱滅
菌することを特徴とする液剤の滅菌法。
1. A method for sterilizing a one-part liquid preparation containing reducing sugar and bicarbonate, wherein the liquid preparation is contained in a soft plastic bag, and then the soft plastic bag containing the liquid preparation is provided with a gas barrier property. A liquid agent sterilization method characterized by wrapping in a high packaging material and heat sterilization.
JP6310264A 1994-12-14 1994-12-14 Method for sterilizing liquid agent made into single agent containing reducing sugar and bicarbonate Pending JPH08164186A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP6310264A JPH08164186A (en) 1994-12-14 1994-12-14 Method for sterilizing liquid agent made into single agent containing reducing sugar and bicarbonate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6310264A JPH08164186A (en) 1994-12-14 1994-12-14 Method for sterilizing liquid agent made into single agent containing reducing sugar and bicarbonate

Publications (1)

Publication Number Publication Date
JPH08164186A true JPH08164186A (en) 1996-06-25

Family

ID=18003154

Family Applications (1)

Application Number Title Priority Date Filing Date
JP6310264A Pending JPH08164186A (en) 1994-12-14 1994-12-14 Method for sterilizing liquid agent made into single agent containing reducing sugar and bicarbonate

Country Status (1)

Country Link
JP (1) JPH08164186A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09291035A (en) * 1996-03-01 1997-11-11 Otsuka Pharmaceut Factory Inc Fat emulsion
WO1999004799A1 (en) * 1996-03-01 1999-02-04 Otsuka Pharmaceutical Factory, Inc. Fatty emulsions containing reducing sugar and method for sterilizing the same
JP2005530537A (en) * 2002-06-07 2005-10-13 バクスター インターナショナル インコーポレイテッド Bicarbonate-based solution in a single container
DE102005030011A1 (en) * 2005-06-17 2006-12-21 Aesculap Ag & Co. Kg Process for the preparation of sterile polysaccharide solutions

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09291035A (en) * 1996-03-01 1997-11-11 Otsuka Pharmaceut Factory Inc Fat emulsion
WO1999004799A1 (en) * 1996-03-01 1999-02-04 Otsuka Pharmaceutical Factory, Inc. Fatty emulsions containing reducing sugar and method for sterilizing the same
EP0998935A1 (en) * 1996-03-01 2000-05-10 Otsuka Pharmaceutical Factory, Inc. Fatty emulsions containing reducing sugar and method for sterilizing the same
EP0998935A4 (en) * 1996-03-01 2001-11-14 Otsuka Pharma Co Ltd Fatty emulsions containing reducing sugar and method for sterilizing the same
US6461633B1 (en) 1997-07-25 2002-10-08 Otsuka Pharmaceutical Factory, Inc. Reducing sugar-containing fat emulsion and a method for its sterilization
KR100438346B1 (en) * 1997-07-25 2004-07-02 가부시키가이샤 오츠까 세이야꾸 고죠 Fatty emulsions containing reducing sugar and method for sterilizing the same
JP2005530537A (en) * 2002-06-07 2005-10-13 バクスター インターナショナル インコーポレイテッド Bicarbonate-based solution in a single container
DE102005030011A1 (en) * 2005-06-17 2006-12-21 Aesculap Ag & Co. Kg Process for the preparation of sterile polysaccharide solutions

Similar Documents

Publication Publication Date Title
AU779950B2 (en) Bicarbonate-based solution in two parts for peritoneal dialysis or substitution in continuous renal replacement therapy
US9254356B2 (en) Dialysis system for preparing a citrate dialysate from a base concentrate and an acid concentrate
US3993751A (en) Process for stabilizing therapeutic compositions and article
JP3060133U (en) Eye perfusion / wash bag package
JP2811035B2 (en) Bicarbonate blended liquid and its container
TWI319984B (en) Sterile combined preparation
JP2000245826A (en) Neutral peritoneal dialysate
JPH08164186A (en) Method for sterilizing liquid agent made into single agent containing reducing sugar and bicarbonate
JP4041171B2 (en) Platelet preservation solution
JPH02304026A (en) Liquid for peritoneal lavage
JP3271650B2 (en) Bicarbonate ion-containing aseptic combination liquid preparation or preparation and method for producing the same
JP7246203B2 (en) hemofiltration replenisher
US20060079464A1 (en) Peritoneal dialysate containing taurine
JP2004154558A (en) Multi-chamber container for storing fluid replacement for filtration type artificial kidney
JP3375518B2 (en) Injection
JP2002308782A (en) Method for producing bicarbonate solution
WO2016027836A1 (en) Platelet wash/replacement solution
JP2001192069A (en) Package for container filled with chemicals containing bicarbonate
JP4040134B2 (en) Bicarbonate ion-containing sterile injection solution and method for producing the same
JP2002145782A (en) Glucose-containing pharmaceutical preparation and method for producing the same
JP2006223897A (en) Multi-chamber container preparation for storing replenishment fluid
JP2000126273A (en) Eye perfusion and washing liquid bag
JP2005053872A (en) Sugar electrolyte maintenance transfusion solution